Purified anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1-M1slash70_Purified_042706
C57BL/6 mouse bone marrow cells were stained with purified CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC (gated on total cells).
  • 1-M1slash70_Purified_042706
    C57BL/6 mouse bone marrow cells were stained with purified CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC (gated on total cells).
  • 2-M170_Pure_CD11b_Antibody_IHC_102418
    Fresh, frozen mouse spleen was stained with purified CD11b clone M1/70 conjugated and detected with a Cy5 CODEX™ oligonucleotide duplex (red). Samples were counterstained with TCR FITC (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Cat # Size Price Quantity Check Availability Save
101201 50 µg 20,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101202 500 µg 76,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse, Human, Cross-Reactivity: Chimpanzee, Baboon, Cynomolgus, Rhesus, Rabbit (Lapine)
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF® - Verified
IP, ICC - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, and immunohistochemistry of acetone-fixed frozen sections5,11-13. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Product Citations
  1. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  2. Madsen D, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.12.011. PubMed
  3. Bachran C, et al. 2017. Sci Rep.. 10.1038/s41598-017-17948-0. PubMed
  4. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  5. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  6. Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed
  7. Zhou N et al. 2018. Protein & cell. 10(2):87-103 . PubMed
  8. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  9. Peterson EJ, et al. 2019. Mol Syst Biol. 15:e8584. PubMed
  10. Wagner J et al. 2019. Cell. 177(5):1330-1345 . PubMed
  11. Torika N, et al. 2018. CNS Neurosci Ther. 24:231. PubMed
  12. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  13. Zhou LJ et al. 2019. Cell Rep. 27(13):3844-3859 . PubMed
  14. Peng J, et al. 2019. Mol Brain. 12:71. PubMed
  15. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  16. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  17. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  18. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  19. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  20. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  21. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  22. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  23. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  24. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  25. Goel S, et al. 2017. Nature. 548:471. PubMed
  26. Yamasaki T, et al. 2018. J Virol. 92:e01458. PubMed
  27. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  28. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  29. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  30. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  31. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  32. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  33. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  34. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  35. Wicki S, et al. 2018. Int J Mol Sci. 1.266666667. PubMed
  36. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  37. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  38. Tong CF, et al. 2018. Am J Physiol Cell Physiol. 315:C409. PubMed
  39. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  40. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  41. Chung MI, et al. 2018. Am J Respir Cell Mol Biol. 59:706. PubMed
  42. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  43. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  44. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  45. Haney MS, et al. 2018. Nat Genet. 50:1716. PubMed
  46. Wang Y, et al. 2019. Biomed Res Int. 2019:5756189. PubMed
  47. Tang B, et al. 2019. Oncolytic Virother. 8:03. PubMed
  48. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  49. Yang C, et al. 2019. MBio. 10:e00595-19. PubMed
  50. Hsieh JY, et al. 2019. APL Bioeng. 3:016103. PubMed
  51. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  52. Andrews AR, et al. 2019. Cancer Cell Int. 0.955555556. PubMed
  53. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  54. Larson–Casey JL, et al. 2019. J Clin Invest. 129:4962. PubMed
  55. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  56. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  57. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  58. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  59. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  60. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  61. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  62. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  63. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  64. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  65. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  66. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  67. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  68. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  69. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  70. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  71. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  72. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  73. Kim SJ, et al. 2017. Nat Immunol. 18:1016. PubMed
  74. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  75. Umemoto T, et al. 2017. EMBO J. 36:2390. PubMed
  76. Kapellos TS, et al. 2017. Mediators Inflamm. 2017:4315412. PubMed
  77. Nascimento DC, et al. 2017. Nat Commun. 8:14919. PubMed
  78. Daley D, et al. 2017. Nat Med. 23:556. PubMed
  79. Hoffmann FM, et al. 2018. Front Immunol. 9:1046. PubMed
  80. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  81. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  82. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  83. Feng L, et al. 2019. Glia. 67:1434. PubMed
  84. Kang SH, et al. 2018. Oncoimmunology. 8:e1515057. PubMed
  85. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  86. Taki M, et al. 2018. Nat Commun. 1.545138889. PubMed
  87. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  88. Majer O, et al. 2019. Nature. 575:366. PubMed
  89. Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
  90. Vinaik R, et al. 2019. Am J Physiol Endocrinol Metab. 317:E751. PubMed
  91. Olver S, et al. 2005. Cancer Res. 66:571. PubMed
  92. Elgazar-Carmon V, et al. 2008. J Lipid Res. 49:1849. PubMed
  93. Guo Y, et al. 2008. Blood. 112:480. PubMed
  94. Kim D, et al. 2008. Blood. 112:1109. PubMed
  95. Napimoga M, et al. 2008. J Immunol. 180:609. PubMed
  96. Baumgartner C, et al. 2010. J Immunol. 184:573. PubMed
  97. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  98. Sun Y, et al. 2015. Proc Natl Acad Sci U S A. 112: 10401-10406. PubMed
  99. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  100. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  101. Francis M, et al. 2017. Toxicol Sci. 155(1):182-195. PubMed
  102. Galbas T, et al. 2017. J Immunol. 198(2):852-861. PubMed
  103. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  104. Coden ME, et al. 2020. J Immunol. 204:438. PubMed
  105. Weidner H, et al. 2020. JCI Insight. 5:00. PubMed
  106. Huang S, et al. 2020. Cell Rep. 33:108394. PubMed
  107. Li X, et al. 2020. J Clin Invest. 130:4182. PubMed
  108. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  109. Tal MC, et al. 2020. MBio. 11:00. PubMed
  110. Nicolas-Boluda A, et al. 2021. eLife. 10:00. PubMed
  111. Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed
  112. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
RRID
AB_312784 (BioLegend Cat. No. 101201)
AB_312785 (BioLegend Cat. No. 101202)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 12.13.2019

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account